knowledge
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: Grail is spending more than ever lobbying Congress
Next article: Grail is spending more than ever lobbying Congress
hotspot
knowledge
-
Duchenne patients, backed by ‘dark money’ group, to debate drug prices
2025-09-30 00:30 -
Listen: Biogen's messy board & Laronde's data problem
2025-09-30 00:08 -
FDA advisers vote against ALS treatment from BrainStorm
2025-09-29 22:53 -
Meta looks to target Twitter with a rival app called Threads
2025-09-29 22:39 -
Why is France rioting? What to know about the fatal police shooting of Nahel M
2025-09-29 22:22 -
Kaiser Permanente unions announce official strike date
2025-09-29 22:14